Invesco Ltd. Increases Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Invesco Ltd. grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 4,963,409 shares of the company's stock after acquiring an additional 17,552 shares during the period. Invesco Ltd. owned about 3.98% of Henry Schein worth $343,468,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Versant Capital Management Inc increased its position in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares during the period. Venturi Wealth Management LLC increased its position in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares during the period. Quent Capital LLC increased its position in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after buying an additional 323 shares during the period. Smartleaf Asset Management LLC raised its stake in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares during the last quarter. Finally, City State Bank acquired a new position in Henry Schein in the fourth quarter valued at $55,000. Institutional investors own 96.62% of the company's stock.

Insider Buying and Selling

In related news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Stock Performance

NASDAQ:HSIC traded down $1.62 during trading on Tuesday, reaching $63.99. The company's stock had a trading volume of 371,233 shares, compared to its average volume of 1,601,802. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The firm has a market cap of $7.95 billion, a price-to-earnings ratio of 26.33, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The firm has a 50 day moving average of $71.58 and a 200-day moving average of $72.19. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter last year, the business posted $0.66 EPS. The business's quarterly revenue was up 5.8% on a year-over-year basis. Research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several research analyst reports. Barrington Research reissued an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. StockNews.com raised shares of Henry Schein from a "hold" rating to a "buy" rating in a research note on Wednesday, April 9th. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and raised their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company started coverage on Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective for the company. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.